Welcome to our dedicated page for Teladoc Health news (Ticker: TDOC), a resource for investors and traders seeking the latest updates and insights on Teladoc Health stock.
Teladoc Health, Inc. (NYSE: TDOC) is described as the global leader in virtual care, and the news surrounding the company reflects its focus on virtual urgent care, integrated care programs and financial performance. Company news includes announcements about enhancements to its 24/7 Care service, participation in major healthcare investor conferences, quarterly earnings results and leadership changes.
Recent updates highlight Teladoc Health’s work to expand its flagship 24/7 Care virtual urgent care service. The company has announced new capabilities that allow licensed care providers to treat a broader range of conditions, consult with board-certified specialists during visits, support preventive care using integrated claims and Health Information Exchange data, connect members to additional Teladoc Health programs and in-network providers, and check prescription benefits in real time through its Prism care delivery platform.
Investors and analysts can also find earnings-related news, including quarterly financial results for the Integrated Care and BetterHelp segments, revenue by type and geography, and non-GAAP measures such as adjusted EBITDA. Teladoc Health regularly issues press releases about its financial outlook, cash flow, and capital structure decisions, including the establishment of a senior secured revolving credit facility.
Other news items cover corporate governance and leadership developments, such as executive transitions and Board changes, as well as Teladoc Health’s participation in industry conferences and collaborations with other virtual care technology providers. This news page aggregates these updates so readers can follow Teladoc Health’s operational, strategic and financial developments over time.
Teladoc Health (NYSE: TDOC) on January 12, 2026 launched enhanced 24/7 Care nationwide, expanding its virtual urgent care capabilities. Enhancements enable care teams to treat a broader range of conditions (eg, back and joint pain, hair loss, sleep issues), support medication optimization for hypertension, diabetes, asthma and COPD, and access board-certified specialists via seconds‑long provider-to-provider consults.
The service now integrates claims and HIE data to prompt preventive actions (70% of members agreed to recommendations) and displays prescription benefits in real time; recent data show >95% of member concerns are resolved in a single visit. The update is powered by the Prism care delivery platform and connects patients to in-network care and Teladoc programs.
Teladoc Health (NYSE: TDOC) said CEO Chuck Divita will present at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco on Monday, January 12, 2026 at 3:45 p.m. PT (6:45 p.m. ET). A live audio webcast and replay will be available on the company's investor relations site.
Investors can listen live or view the replay at the investor events page: https://ir.teladochealth.com/news-and-events/events-and-presentations.
Teladoc Health (NYSE: TDOC) announced that CEO Chuck Divita will participate in the 37th Annual Piper Sandler Healthcare Conference in New York on Tuesday, December 2, 2025 at 12:30 p.m. ET.
A live audio webcast and replay will be available via the company’s investor events page at http://ir.teladochealth.com/news-and-events/events-and-presentations/. Contact for investors is Michael Minchak at IR@teladochealth.com or 617-444-9612.
TytoCare will integrate its FDA-cleared home diagnostic technology with Teladoc Health (NYSE: TDOC) to augment Primary360 and 24/7 Care programs. The integration will begin in 2026 with a phased rollout to select customers and enables remote clinical-grade exams (lungs, throat, ear, heart, skin, temperature) using TytoCare's handheld device and AI-powered Lung Sounds Suite.
Key facts: FDA clearance for the AI Lung Sounds Suite; respiratory conditions represent >40% of TytoCare diagnoses; AI trained on >7 million exams.
Teladoc Health (NYSE:TDOC) announced an employment inducement award effective November 1, 2025 for new Chief Technology Officer Dave Ross. The grant includes 86,906 restricted stock units (RSUs) and 86,906 performance stock units (PSUs) at target (up to 173,812 shares if maximum is earned).
The RSUs vest with one-third on the first anniversary and the remainder quarterly over the next two years. The PSUs are earned over a three-year performance period based on specified financial metrics. The award was approved by the Compensation Committee and granted under the Teladoc Health 2023 Employment Inducement Incentive Award Plan as permitted by NYSE Rule 303A.08.
Teladoc Health (NYSE: TDOC) reported Third Quarter 2025 results for the period ended September 30, 2025. Revenue was $626.4M, down 2% year‑over‑year; net loss was $49.5M, or $0.28 per share; and adjusted EBITDA was $69.9M, down 16% year‑over‑year. Integrated Care revenue rose 2% to $389.5M with a 17.0% adjusted EBITDA margin; BetterHelp revenue fell 8% to $236.9M with a 1.6% adjusted EBITDA margin. Third Quarter results included a $12.6M goodwill impairment and $17.0M stock‑based compensation. Full‑year 2025 guidance: revenue $2,510–2,539M; adjusted EBITDA $270–287M; FCF $170–185M.
Teladoc Health (NYSE: TDOC) announced a CFO transition and provided preliminary third-quarter 2025 financial results on October 23, 2025. Mala Murthy will step down as CFO and remain in the role through November 21, 2025; an interim finance structure will report to CEO Chuck Divita while a search is conducted.
The company reaffirmed its full-year 2025 consolidated revenue and adjusted EBITDA outlook and reported preliminary unaudited Q3 2025 results: consolidated revenue $626.4 million and consolidated adjusted EBITDA $69.9 million. A conference call to discuss Q3 results is scheduled for October 29, 2025 at 5:00 p.m. ET.
Teladoc Health (NYSE: TDOC) will release third quarter 2025 financial results on Wednesday, October 29, 2025 after the market close.
The company will host a conference call to review results at 5:00 p.m. ET the same day. U.S. participants can dial 1-833-470-1428 and use access code 609817. International dial-in numbers are available via the global numbers page. A live audio webcast will be available at the investor events page, and a replay will be posted there for on-demand listening for approximately 90 days.
Teladoc Health (NYSE: TDOC) launched a new workplace safety capability within its AI-enabled Clarity monitoring solution to help hospitals and health systems detect and intervene in escalating incidents.
The capability uses video and audio cues to analyze facial expressions, threatening gestures, and aggressive language, providing intelligent notifications to care teams for early intervention. Teladoc cited workforce safety data including that more than 80% of nurses have experienced workplace violence and that healthcare workers are five times more likely to face workplace violence than other industries; a report estimates workplace and community violence costs hospitals more than $18 billion annually.
The solution will be implemented with select hospitals and health systems in Q1 2026 as part of Teladoc's partner development program.
Teladoc Health (NYSE:TDOC) reported mixed Q2 2025 results with revenue declining 2% year-over-year to $631.9 million. The company posted a net loss of $32.7 million ($0.19 per share), significantly improved from the $837.7 million loss in Q2 2024. Adjusted EBITDA decreased 23% to $69.3 million.
The Integrated Care segment showed growth with revenue up 4% to $391.5 million, while BetterHelp segment revenue declined 9% to $240.4 million. The company secured a new $300 million revolving credit facility and paid $550.6 million to retire convertible senior notes. For full-year 2025, Teladoc expects revenue between $2.501-$2.548 billion and projects continued challenges in the BetterHelp segment with revenue declining 6.8-9.2%.
FAQ
What is the current stock price of Teladoc Health (TDOC)?
What is the market cap of Teladoc Health (TDOC)?
